Arkolith/Insider Trading/JNCE/Form 4

Tang Capital Management LLC

10% OwnerJounce Therapeutics, Inc. (JNCE) · full profile →Form 4 · filed Mar 14, 2023
Net Buying
Open-Market Buys
$86K
Open-Market Sells
$0
Net Open-Market Flow
$86K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2023Buy(P)20K$1.02$21K5.3M
Mar 13, 2023Buy(P)66K$0.99$65K5.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-018721) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML